PIK3R2

PIK3R2 (phosphatidylinositol 3-kinase regulatory subunit 2) is a protein-coding gene located on chromosome 1q42.2 in humans. It encodes the p85β regulatory subunit of class IA phosphoinositide 3‑kinase (PI3K), which modulates the catalytic activity of the p110α, p110β, and p110δ catalytic subunits. The p85β protein is composed of an N‑terminal SH2-ABD domain, a central proline‐rich region, a C2 domain, and a C‑terminal SH2 domain. These structural elements allow p85β to bind phosphorylated tyrosine residues on receptor tyrosine kinases and to stabilize and regulate the catalytic subunit.

Functionally, PIK3R2 participates in signal transduction pathways that control cell growth, survival, metabolism, and migration. By forming heterodimers with the catalytic subunits, p85β maintains them in an inactive conformation until receptor engagement relieves this inhibition. Once activated, the PI3K complex phosphorylates phosphatidylinositol (4,5)‑bisphosphate (PIP2) to generate phosphatidylinositol (3,4,5)‑trisphosphate (PIP3), which recruits downstream effectors such as AKT. p85β also acts as a scaffolding protein, interacting with components of the MAPK pathway and with proteins involved in endocytosis.

Clinical significance: Genetic variations in PIK3R2 have been implicated in intellectual disability disorders (e.g., syndromic forms of neurodevelopmental delay) due to haploinsufficiency. Somatic mutations of PIK3R2 are less frequent than those of catalytic PI3K subunits but have been identified in certain cancers, including glioblastoma and colorectal carcinoma, where they may contribute to aberrant PI3K signaling. Polymorphisms in the gene have been studied in relation to metabolic syndrome and type 2 diabetes, suggesting a role in insulin signaling regulation.

Interaction networks: PIK3R2 interacts with growth factor receptors (EGFR, PDGFRA), adaptor proteins (GRB2, SHC), and the catalytic PI3K subunits (PIK3CA, PIK3CB, PIK3CD). It also binds to the Shc protein’s phosphotyrosine residues, facilitating signal propagation to the PI3K complex. Through its SH2 domains, p85β competes with other SH2 domain‑containing molecules for binding sites, thereby fine‑tuning signal intensity.

Research references and further reading are available in the GeneReviews database, the NCBI Gene portal, and peer‑reviewed articles in journals such as the Journal of Biological Chemistry and the American Journal of Human Genetics.